Cargando…

A neural network-based method for polypharmacy side effects prediction

BACKGROUND: Polypharmacy is a type of treatment that involves the concurrent use of multiple medications. Drugs may interact when they are used simultaneously. So, understanding and mitigating polypharmacy side effects are critical for patient safety and health. Since the known polypharmacy side eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Masumshah, Raziyeh, Aghdam, Rosa, Eslahchi, Changiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305591/
https://www.ncbi.nlm.nih.gov/pubmed/34303360
http://dx.doi.org/10.1186/s12859-021-04298-y
_version_ 1783727610464829440
author Masumshah, Raziyeh
Aghdam, Rosa
Eslahchi, Changiz
author_facet Masumshah, Raziyeh
Aghdam, Rosa
Eslahchi, Changiz
author_sort Masumshah, Raziyeh
collection PubMed
description BACKGROUND: Polypharmacy is a type of treatment that involves the concurrent use of multiple medications. Drugs may interact when they are used simultaneously. So, understanding and mitigating polypharmacy side effects are critical for patient safety and health. Since the known polypharmacy side effects are rare and they are not detected in clinical trials, computational methods are developed to model polypharmacy side effects. RESULTS: We propose a neural network-based method for polypharmacy side effects prediction (NNPS) by using novel feature vectors based on mono side effects, and drug–protein interaction information. The proposed method is fast and efficient which allows the investigation of large numbers of polypharmacy side effects. Our novelty is defining new feature vectors for drugs and combining them with a neural network architecture to apply for the context of polypharmacy side effects prediction. We compare NNPS on a benchmark dataset to predict 964 polypharmacy side effects against 5 well-established methods and show that NNPS achieves better results than the results of all 5 methods in terms of accuracy, complexity, and running time speed. NNPS outperforms about 9.2% in Area Under the Receiver-Operating Characteristic, 12.8% in Area Under the Precision–Recall Curve, 8.6% in F-score, 10.3% in Accuracy, and 18.7% in Matthews Correlation Coefficient with 5-fold cross-validation against the best algorithm among other well-established methods (Decagon method). Also, the running time of the Decagon method which is 15 days for one fold of cross-validation is reduced to 8 h by the NNPS method. CONCLUSIONS: The performance of NNPS is benchmarked against 5 well-known methods, Decagon, Concatenated drug features, Deep Walk, DEDICOM, and RESCAL, for 964 polypharmacy side effects. We adopt the 5-fold cross-validation for 50 iterations and use the average of the results to assess the performance of the NNPS method. The evaluation of the NNPS against five well-known methods, in terms of accuracy, complexity, and running time speed shows the performance of the presented method for an essential and challenging problem in pharmacology. Datasets and code for NNPS algorithm are freely accessible at https://github.com/raziyehmasumshah/NNPS. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-021-04298-y.
format Online
Article
Text
id pubmed-8305591
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83055912021-07-28 A neural network-based method for polypharmacy side effects prediction Masumshah, Raziyeh Aghdam, Rosa Eslahchi, Changiz BMC Bioinformatics Research BACKGROUND: Polypharmacy is a type of treatment that involves the concurrent use of multiple medications. Drugs may interact when they are used simultaneously. So, understanding and mitigating polypharmacy side effects are critical for patient safety and health. Since the known polypharmacy side effects are rare and they are not detected in clinical trials, computational methods are developed to model polypharmacy side effects. RESULTS: We propose a neural network-based method for polypharmacy side effects prediction (NNPS) by using novel feature vectors based on mono side effects, and drug–protein interaction information. The proposed method is fast and efficient which allows the investigation of large numbers of polypharmacy side effects. Our novelty is defining new feature vectors for drugs and combining them with a neural network architecture to apply for the context of polypharmacy side effects prediction. We compare NNPS on a benchmark dataset to predict 964 polypharmacy side effects against 5 well-established methods and show that NNPS achieves better results than the results of all 5 methods in terms of accuracy, complexity, and running time speed. NNPS outperforms about 9.2% in Area Under the Receiver-Operating Characteristic, 12.8% in Area Under the Precision–Recall Curve, 8.6% in F-score, 10.3% in Accuracy, and 18.7% in Matthews Correlation Coefficient with 5-fold cross-validation against the best algorithm among other well-established methods (Decagon method). Also, the running time of the Decagon method which is 15 days for one fold of cross-validation is reduced to 8 h by the NNPS method. CONCLUSIONS: The performance of NNPS is benchmarked against 5 well-known methods, Decagon, Concatenated drug features, Deep Walk, DEDICOM, and RESCAL, for 964 polypharmacy side effects. We adopt the 5-fold cross-validation for 50 iterations and use the average of the results to assess the performance of the NNPS method. The evaluation of the NNPS against five well-known methods, in terms of accuracy, complexity, and running time speed shows the performance of the presented method for an essential and challenging problem in pharmacology. Datasets and code for NNPS algorithm are freely accessible at https://github.com/raziyehmasumshah/NNPS. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-021-04298-y. BioMed Central 2021-07-24 /pmc/articles/PMC8305591/ /pubmed/34303360 http://dx.doi.org/10.1186/s12859-021-04298-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Masumshah, Raziyeh
Aghdam, Rosa
Eslahchi, Changiz
A neural network-based method for polypharmacy side effects prediction
title A neural network-based method for polypharmacy side effects prediction
title_full A neural network-based method for polypharmacy side effects prediction
title_fullStr A neural network-based method for polypharmacy side effects prediction
title_full_unstemmed A neural network-based method for polypharmacy side effects prediction
title_short A neural network-based method for polypharmacy side effects prediction
title_sort neural network-based method for polypharmacy side effects prediction
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305591/
https://www.ncbi.nlm.nih.gov/pubmed/34303360
http://dx.doi.org/10.1186/s12859-021-04298-y
work_keys_str_mv AT masumshahraziyeh aneuralnetworkbasedmethodforpolypharmacysideeffectsprediction
AT aghdamrosa aneuralnetworkbasedmethodforpolypharmacysideeffectsprediction
AT eslahchichangiz aneuralnetworkbasedmethodforpolypharmacysideeffectsprediction
AT masumshahraziyeh neuralnetworkbasedmethodforpolypharmacysideeffectsprediction
AT aghdamrosa neuralnetworkbasedmethodforpolypharmacysideeffectsprediction
AT eslahchichangiz neuralnetworkbasedmethodforpolypharmacysideeffectsprediction